CardioDx’s Leadership to Speak at the 5th Annual Personalized Medicine World Conference

PALO ALTO, Calif.–(BUSINESS WIRE)– CardioDx, Inc. announced today that President and CEO, David Levison, and Chief Medical Officer, Mark Monane, M.D., will present at the 5th Annual Personalized Medicine World Conference (PMWC) on Tuesday, January 29, 2013 in Mountain View, CA. Continue reading

Hematology Diagnosis and – Video




Hematology Diagnosis and Buy from Amazon CA Site www.amazon.ca Product Description Hematology Diagnosis and Hematology, 6th Edition encompasses all of the latest scientific knowledge and clinical solutions in the field, equipping you with the expert answers you need to offer your patients the best possible outcomes. Ronald Hoffman, MD, Edward J. Continue reading

Eugenics: Epigenetics, subhumanz, and the biofield (live and let live) – Video




Eugenics: Epigenetics, subhumanz, and the biofield (live and let live) Some more strategies and solutions to what I'm discussing here will be included in coming vlogs. This one is pretty conversational and straightforward even tho I'm a bit tired. I also go into a bit about the whole “organic portal” thing and why I don't fully agree with the party line about it. Continue reading

Humans, chimpanzees and monkeys share DNA but not gene regulatory mechanisms

Public release date: 6-Nov-2012 [ | E-mail | Share ] Contact: Cathy Yarbrough press@ashg.org 858-243-1814 American Society of Human Genetics Humans share over 90% of their DNA with their primate cousins. The expression or activity patterns of genes differ across species in ways that help explain each species’ distinct biology and behavior. Continue reading

New insights into why humans are more susceptible to cancer and other diseases

Public release date: 23-Aug-2012 [ | E-mail | Share ] Contact: Mary Beth O’Leary moleary@cell.com 617-397-2802 Cell Press Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what’s their secret Continue reading

Novel gene therapy approach may treat dysferlinopathies

The challenge of treating patients with genetic disorders in which a single mutated gene is simply too large to be replaced using traditional gene therapy techniques may soon be a thing of the past. A Nationwide Children’s Hospital study describes a new gene therapy approach capable of delivering full-length versions of large genes and improving skeletal muscle function Continue reading

New gene transfer strategy shows promise for limb girdle and other muscular dystrophies

Public release date: 9-Jul-2012 [ | E-mail | Share ] Contact: Erin Pope Erin.Pope@NationwideChildrens.org 614-355-0495 Nationwide Children’s Hospital The challenge of treating patients with genetic disorders in which a single mutated gene is simply too large to be replaced using traditional gene therapy techniques may soon be a thing of the past. A Nationwide Children’s Hospital study describes a new gene therapy approach capable of delivering full-length versions of large genes and improving skeletal muscle function. Continue reading

UMass Medical School researchers discover a new role for RNAi

Public release date: 26-Jun-2012 [ | E-mail | Share ] Contact: Jim Fessenden james.fessenden@umassmed.edu 508-856-2000 University of Massachusetts Medical School WORCESTER, MA Organisms employ a fascinating array of strategies to identify and restrain invasive pieces of foreign DNA, such as those introduced by viruses. Continue reading

Veracyte Announces Study Results Published Online in New England Journal of Medicine Which Suggest that Its Afirma® …

HOUSTON, June 25, 2012 /PRNewswire/ –Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a large, prospective, multicenter study, which demonstrated the potential for the Afirma Gene Expression Classifier, a gene expression test, to reduce the large number of unnecessary surgeries in thyroid cancer diagnosis by more than half. (Logo: http://photos.prnewswire.com/prnh/20120625/SF29625LOGO) The results are being shared during a late-breaking data presentation at The Endocrine Society’s ENDO 2012: The 94th Annual Meeting & Expo in Houston, Texas, and coincide with online publication by the New England Journal of Medicine. The study is scheduled to appear in the journal’s August 23, 2012 print issue. Continue reading

Gene expression and peripheral blood as tools for pinpointing genes linked to autism

UCLA researchers have combined two tools – gene expression and the use of peripheral blood — to expand scientists’ arsenal of methods for pinpointing genes that play a role in autism. Published in the June 21 online edition of the American Journal of Human Genetics, the findings could help scientists zero in on genes that offer future therapeutic targets for the disorder Continue reading

Study explains functional links between autism and genes

Public release date: 21-Jun-2012 [ | E-mail | Share ] Contact: Mary Beth O’Leary moleary@cell.com 617-397-2802 Cell Press A pioneering report of genome-wide gene expression in autism spectrum disorders (ASDs) finds genetic changes that help explain why one person has an ASD and another does not. The study, published by Cell Press on June 21 in The American Journal of Human Genetics, pinpoints ASD risk factors by comparing changes in gene expression with DNA mutation data in the same individuals. This innovative approach is likely to pave the way for future personalized medicine, not just for ASD but also for any disease with a genetic component Continue reading

Genetic test can accurately predict spread of eye cancer

Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver. In 459 patients with ocular melanoma at 12 centers in the United States and Canada, the researchers found the test could successfully classify tumors more than 97 percent of the time. Continue reading

Genetic test identifies eye cancer tumors likely to spread

Public release date: 14-May-2012 [ | E-mail | Share ] Contact: Jim Dryden jdryden@wustl.edu 314-286-0110 Washington University School of Medicine Researchers at Washington University School of Medicine in St. Continue reading